16 research outputs found

    Minimally invasive versus open transforaminal lumbar interbody fusion: evaluating initial experience

    Get PDF
    The aim of this study was to compare our experience with minimally invasive transforaminal lumbar interbody fusion (MITLIF) and open midline transforaminal lumbar interbody fusion (TLIF). A total of 36 patients suffering from isthmic spondylolisthesis or degenerative disc disease were operated with either a MITLIF (n = 18) or an open TLIF technique (n = 18) with an average follow-up of 22 and 24months, respectively. Clinical outcome was assessed using the visual analogue scale (VAS) and the Oswestry disability index (ODI). There was no difference in length of surgery between the two groups. The MITLIF group resulted in a significant reduction of blood loss and had a shorter length of hospital stay. No difference was observed in postoperative pain, initial analgesia consumption, VAS or ODI between the groups. Three pseudarthroses were observed in the MITLIF group although this was not statistically significant. A steeper learning effect was observed for the MITLIF grou

    Anterior Cruciate Ligament Reconstruction with a Four-Strand Hamstring Tendon Autograft

    Full text link

    Improving Embryonic Stem Cell Expansion through the Combination of Perfusion and Bioprocess Model Design

    Get PDF
    <div><p>Background</p><p>High proliferative and differentiation capacity renders embryonic stem cells (ESCs) a promising cell source for tissue engineering and cell-based therapies. Harnessing their potential, however, requires well-designed, efficient and reproducible expansion and differentiation protocols as well as avoiding hazardous by-products, such as teratoma formation. Traditional, standard culture methodologies are fragmented and limited in their fed-batch feeding strategies that afford a sub-optimal environment for cellular metabolism. Herein, we investigate the impact of metabolic stress as a result of inefficient feeding utilizing a novel perfusion bioreactor and a mathematical model to achieve bioprocess improvement.</p><p>Methodology/Principal Findings</p><p>To characterize nutritional requirements, the expansion of undifferentiated murine ESCs (mESCs) encapsulated in hydrogels was performed in batch and perfusion cultures using bioreactors. Despite sufficient nutrient and growth factor provision, the accumulation of inhibitory metabolites resulted in the unscheduled differentiation of mESCs and a decline in their cell numbers in the batch cultures. In contrast, perfusion cultures maintained metabolite concentration below toxic levels, resulting in the robust expansion (>16-fold) of high quality ‘naïve’ mESCs within 4 days. A multi-scale mathematical model describing population segregated growth kinetics, metabolism and the expression of selected pluripotency (‘stemness’) genes was implemented to maximize information from available experimental data. A global sensitivity analysis (GSA) was employed that identified significant (6/29) model parameters and enabled model validation. Predicting the preferential propagation of undifferentiated ESCs in perfusion culture conditions demonstrates synchrony between theory and experiment.</p><p>Conclusions/Significance</p><p>The limitations of batch culture highlight the importance of cellular metabolism in maintaining pluripotency, which necessitates the design of suitable ESC bioprocesses. We propose a novel investigational framework that integrates a novel perfusion culture platform (controlled metabolic conditions) with mathematical modeling (information maximization) to enhance ESC bioprocess productivity and facilitate bioprocess optimization.</p></div

    Perfusion culture growth kinetics, viability and metabolism.

    No full text
    <p>a) Total number of viable ESCs; experimental (□) and model predictions (–); b) Simulation results the cellular states of ‘naïve’ (<i>X<sub>U</sub></i>) and ‘primed’ (<i>X<sub>D</sub></i>) mESCs; c) Micrographs of the mESCs encapsulated in the alginate hydrogels at day 9 (i, ii); Live (green)/dead (red) fluorescence micrographs showing the live cells (iii) forming large colonies of 300–400 µm in diameter with minimal dead cells (iv) at day 9; d) experimental (symbols) and simulation (lines) glucose and lactate concentration profiles; e) experimental (symbols) and simulation (lines) glutamine and ammonia concentration profiles. Experimental values represent mean±SD, N = 3.</p

    Pluripotency-related gene expression in batch cultures.

    No full text
    <p>Gene expression levels of a) <i>Rex1</i>, b) <i>Oct3/4</i>, c) <i>Fgf5</i>, d) <i>Sox2</i>, e) <i>Dppa3</i> and f) <i>Nanog</i>. Model simulation results are predicted for <i>Rex1</i>, <i>Fgf5</i> and <i>Dppa3</i> (line). *<i>P</i><0.05, one-way ANOVA. Experimental values represent mean±SD, N = 3.</p

    LIF concentration and associated gene expression in batch cultures.

    No full text
    <p>a) LIF growth concentration levels over the 6 day culture period remain significantly higher than the half maximal and differentiation threshold levels. b) Gene expression levels of <i>LIF-Stat3</i> signalling (<i>Socs3</i>, <i>Stat3</i>, <i>Klf4</i>) and <i>BMP-ID</i> signalling (<i>Sox1</i>, <i>Id1</i> and <i>Id3</i>) for control (day 0) and day 6 batch culture values. *<i>P</i><0.05, Student t-test. Experimental values represent mean±SD, N = 3.</p

    LIF concentration and associated gene expression in perfusion cultures.

    No full text
    <p>a) LIF growth concentration levels remain high in both the perfusion and batch cultures throughout the culture period. No difference in LIF concentration between the two operation modes was observed. b) Gene expression levels of <i>LIF-Stat3</i> signalling (<i>Socs3, Stat3, Klf4</i>) and BMP-ID signalling (<i>Sox1, Id1 and Id3</i>) for control (day 0) and day 6 batch culture values. *<i>P</i><0.05, Student t-test. Experimental values represent mean±SD, N = 3.</p

    Batch culture growth kinetics, viability and metabolism.

    No full text
    <p>a) Total number of viable ESCs; experimental (◊) and model predictions (–); b) Simulation results of the different ‘naïve’ (<i>X<sub>U</sub></i>) and ‘primed’ (<i>X<sub>D</sub></i>) mESC sub-populations; c) Micrographs of the mESCs encapsulated in the alginate hydrogels at day 9 (i, ii); Live (green)/dead (red) fluorescence micrographs showing live cells (iii) forming colonies of <200 µm in diameter as well as a high proportion of dead cells (iv) at day 9; d) experimental (symbols) and simulation (lines) glucose and lactate concentration profiles; e) experimental (symbols) and simulation (lines) glutamine and ammonia concentration profiles. Experimental values represent mean±SD, N = 3.</p
    corecore